import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "where-to-buy-hexarelin-research-guide",
  title: "Where to Buy Hexarelin: A Researcher's Sourcing Guide",
  description:
    "What researchers need to know before sourcing Hexarelin — purity benchmarks for this potent GHRP, COA documentation requirements, stability characteristics, and how to distinguish verified research-grade supply from underdosed commodity product.",
  category: "Quality & Testing",
  readMinutes: 9,
  publishedAt: "2026-06-06",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "Hexarelin (Examorelin) is a synthetic hexapeptide growth hormone secretagogue — His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH₂ — and one of the most potent GHRP-class compounds in the research literature. With a molecular weight of 887.04 Da and exceptional GH-releasing potency in animal models, it occupies a distinct position among growth hormone secretagogues: stronger GH pulse amplitude than GHRP-2 or GHRP-6 in equivalent-dose comparisons, with documented cardiac-protective mechanisms that have driven a separate line of cardiovascular research entirely independent of its GH activity.",
    },
    {
      type: "paragraph",
      text: "That research utility makes sourcing quality critical. This guide covers what researchers need to evaluate when purchasing Hexarelin — synthesis chemistry, purity standards, COA requirements, and the stability considerations that affect experimental reproducibility.",
    },
    {
      type: "heading",
      text: "Hexarelin's Chemistry and Why It Matters for Sourcing",
    },
    {
      type: "paragraph",
      text: "Hexarelin's defining structural feature is its D-2-methyltryptophan (D-2-MeTrp) residue at position 2. The methylation at the 2-position of the indole ring is what gives Hexarelin its enhanced potency compared to GHRP-6 — but it also introduces a synthesis complexity that separates research-grade product from commodity supply. D-2-MeTrp is a non-standard amino acid that must be synthesized separately before incorporation into the peptide chain. Suppliers who source low-cost raw materials may use impure or racemized D-2-MeTrp, which directly degrades the biological activity of the final product even if the HPLC trace looks acceptable at low resolution.",
    },
    {
      type: "paragraph",
      text: "At 6 residues, Hexarelin is a short peptide — synthesis is technically tractable — but the non-standard building blocks make it a compound where raw material sourcing (not just synthesis execution) determines quality. A COA that includes mass spectrometry confirmation of the correct molecular weight is the minimum baseline for confidence that the D-2-MeTrp was correctly incorporated.",
    },
    {
      type: "heading",
      text: "Purity Standards for Hexarelin Research",
    },
    {
      type: "paragraph",
      text: "For research-grade Hexarelin, ≥98% HPLC purity (by UV peak area at 220 nm) is the accepted minimum for experimental use. This threshold matters because Hexarelin studies — particularly in cardiac protection and GH secretion models — are sensitive to dose-response relationships. If a researcher is working with a product at 92% purity, approximately 8% of the administered mass consists of synthesis byproducts with unknown receptor pharmacology. In potency-sensitive assays, those impurities introduce noise that can obscure real signal.",
    },
    {
      type: "paragraph",
      text: "The HPLC trace itself should be requested and reviewed, not just the stated percentage. A single clean main peak with minor flanking peaks consistent with known degradation pathways is the expected profile for quality Hexarelin. Multiple large peaks, a broad asymmetric main peak, or a retention time inconsistent with the compound's calculated logP all warrant rejection of the lot.",
    },
    {
      type: "heading",
      text: "What a Complete Hexarelin COA Should Include",
    },
    {
      type: "list",
      items: [
        "HPLC chromatogram with retention time, peak area percentage, and method parameters (column type, mobile phase, UV wavelength)",
        "Mass spectrometry data confirming molecular weight of 887.04 Da — critical for verifying D-2-MeTrp incorporation",
        "Appearance description: white to off-white lyophilized powder",
        "Water content (Karl Fischer titration) — allows calculation of actual peptide content vs. nominal label weight",
        "Endotoxin testing (LAL method, <1.0 EU/mg) for any injectable research application",
        "Lot number and synthesis date enabling batch traceability",
        "Third-party laboratory header — the COA should be issued by an independent testing facility, not the vendor's internal lab",
      ],
    },
    {
      type: "heading",
      text: "The Cardiac Research Context: Why Purity Is Especially Critical",
    },
    {
      type: "paragraph",
      text: "Hexarelin's most distinctive research application — cardiac protection — makes purity particularly non-negotiable. The published literature on Hexarelin's cardioprotective effects involves models of ischemia-reperfusion injury, myocardial infarction, and cardiomyopathy progression. These are high-sensitivity endpoints where a confounding variable introduced by impure peptide can produce false-negative results (failing to observe real protection because the active compound content was insufficient) or false-positive artifacts from byproduct activity.",
    },
    {
      type: "paragraph",
      text: "The mechanism involves CD36 receptor binding — a distinct pathway from the GHS-R1a pathway that mediates GH secretion. This dual-receptor profile is part of what makes Hexarelin scientifically interesting, and it is also why the structural integrity of the compound (confirmed by MS) matters more here than for simpler single-receptor ligands. A synthesis byproduct that retains partial GHS-R1a binding but lacks CD36 activity would produce GH secretion results while failing to replicate cardiac findings — a reproducibility failure that traces back entirely to sourcing.",
    },
    {
      type: "heading",
      text: "Stability and Storage Requirements",
    },
    {
      type: "paragraph",
      text: "Hexarelin in lyophilized form is stable at -20°C for 24+ months when stored in sealed vials under inert atmosphere. The peptide's tryptophan residues — both the standard Trp at position 4 and the modified D-2-MeTrp at position 2 — are susceptible to oxidation under light exposure. Storage in amber or opaque vials is standard practice; vials shipped in clear glass with light exposure during transit should be considered compromised.",
    },
    {
      type: "paragraph",
      text: "Once reconstituted in sterile water or bacteriostatic water, Hexarelin solutions should be stored at 4°C and used within 4 weeks. Freeze-thaw cycles after reconstitution degrade potency — each cycle introduces mechanical stress that disrupts the non-covalent structure of the peptide in solution. Researchers planning multi-week studies should aliquot reconstituted Hexarelin into single-use volumes before freezing.",
    },
    {
      type: "heading",
      text: "Red Flags in the Hexarelin Supply Market",
    },
    {
      type: "list",
      items: [
        "COA without mass spectrometry data — given the non-standard D-2-MeTrp building block, MS verification is not optional",
        "Purity stated as a range (e.g., '≥95%') without an actual measured value from HPLC",
        "No third-party lab attribution on the COA — internal testing has no independent verification",
        "Vials shipped without cold-pack or refrigeration — Hexarelin degrades at ambient temperature over shipping timelines",
        "Unusually low pricing — synthesis of D-2-MeTrp-containing peptides has real raw material costs; prices significantly below market suggest substitution or significant purity compromise",
        "Lot numbers not traceable to specific COA documents — batch-level accountability is a basic quality standard",
      ],
    },
    {
      type: "heading",
      text: "Why Nexphoria",
    },
    {
      type: "paragraph",
      text: "Nexphoria's Hexarelin is synthesized using verified D-2-MeTrp building blocks, with HPLC purity ≥99% and mass spectrometry confirmation on every lot. COAs are issued by independent third-party laboratories and publicly accessible by batch number. Cold-pack shipping is standard on all orders — not an upgrade — because we know that ambient-temperature transit degrades the compounds we've spent considerable effort verifying.",
    },
    {
      type: "paragraph",
      text: "For researchers working in GH axis biology or cardiac protection models, the quality floor for Hexarelin is non-negotiable. We've built our supply chain around meeting it consistently.",
    },
    {
      type: "disclaimer",
      text: "Hexarelin is sold by Nexphoria strictly for in vitro and preclinical research use. It is not approved for human consumption, therapeutic use, or veterinary application. All purchases require agreement to our research-use-only terms.",
    },
  ],
};
